Skip to content
Home/ Nanotechnology for Cancer Therapy
Nanotechnology for Cancer Therapy

Nanotechnology for Cancer Therapy

No customer reviews yet ISBN 9780849371943

While simultaneous breakthroughs occurring in molecular biology and nanoscience/technology will ultimately revolutionize all of medicine, it is with our efforts to prevent, diagnose, and treat cancer that many of the most dramatic advances will occur. In support of this potential, the U.S. National Cancer Institute (NCI) established the Alliance for Nanotechnology in Cancer in 2004 and pledged $144.3 million in funding over the next five years.

Edited by one of the most dynamic pioneers in the field, Nanotechnology for Cancer Therapy focuses on those nanoscientific and nanotechnological strategies that are evolving as the most promising for the imaging and treatment of cancer. Among the various approaches considered, nanotechnology offers great possibilities for the targeted delivery of drugs and genes to tumor sites and the ultimate replacement of those chemotherapeutic agents so compromised by side effects.

Within this volume, the expertise of world-renowned academic and industrial researchers is brought together to provide a comprehensive treatise. Composed of 38 chapters, the book is divided into 7 sections that cover -

  • Fundamentals of targeting strategies, nanotechnology characterization for cancer therapy, and USFDA guidelines on approval of nanotechnology products
  • Polymeric conjugates used for tumor-targeted imaging and delivery, including imaging to evaluate therapeutic efficacy
  • Polymeric nanoparticle systems that emphasize biodegradable, long-circulating nanoparticles for passive and active targeting
  • Polymeric micellar assemblies, where sophisticated chemistry is leading to novel nanosystems that can provide efficient delivery to tumors
  • Dendritic nanostructures used for cancer imaging and therapy
  • Liposome-based delivery systems -- the oldest nanotechnology method employed in cancer therapy
  • Other lipid nanosystems used for targeted delivery, including those tha

    • About the author

    Product details

    Pub dateDec 19, 2006
    ISBN-100849371945
    ISBN-139780849371943
    LanguageEnglish
    Last updated 2026-04-09 06:58
    $439.20
    In stock soon — order now to reserve your copy
    Delivery by Monday, October 12, 2026
    Qty
    Sign in to Add to Saved list
    Free delivery on orders over $35.
    15-day returns. Any reason.
    Secure checkout. We never store card details.

    Readers who bought this also bought

    More from Oncology - General
    See all
    Facing Cancer: A Complete Guide for People with Cancer, Their Families, and Caregivers
    Stern, Theodore
    $20.36
    Cancer Pain Management
    Fisch, Michael
    $251.58
    MD Anderson Manual of Psychosocial Oncology
    Duffy, James D
    $101.14
    Gynecologic Oncology: Clinical Practice and Surgical Atlas
    Karlan, Beth Y
    $320.70
    Harrison's Manual of Oncology
    Chabner, Bruce a
    $95.77
    Advances in Cancer Research
    Volume 68 of <b>Advances in Cancer Research</b> continues the tradition of publishing up-to-date reviews and "hot" topics in cancer research. This volume begins with a "Foundations in Cancer Research" article by Harald zur Hausen that reviews his years of research on the idea that cancer can be triggered by infection. The structure and function of the cytokine receptor superfamily and its association with leukemias are discussed in depth by James Ihle. Marcia Hall and Gordon Peters review the evidence indicating that genetic abnormalities hinder the function of certain cyclins and their inhibitors. The most widely studied protooncogene, c-<i>myc</i>, is reviewed by Marie Henriksson and Bernhard Lüscher&#x3b; the chapter focuses on the function of c-<i>myc</i> as a transcription factor rather than on the effects of gene translocation and activation on malignancies. Ham Werner and Derek LeRoith present data on the role that insulin-like growth factors play on cell growth and regulation. In the final chapter, Olli-P. Kallioniemi and Tapio Visakorpi investigate the field of prostate cancer and, more importantly, the biological reason and natural history behind the growth of this cancer.
    $103.10